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ABSTRACT	 	Renal	 involvement	 in	 Sjogren’s	 syndrome	 (SS)	 is	 not	 uncommon	 and	 may	 precede	 other	 complaints.	Tubulointerstitial	nephritis	is	the	most	common	renal	disease	in	SS	and	may	lead	to	,	renal	tubular	acidosis	(RTA),	 which	 in	 turn	 may	 cause	 osteomalacia.	 Nevertheless,	 osteomalacia	 rarely	 occurs	 as	 the	 first	manifestation	of	a	renal	tubule	connective	tissue	disorder	due	to	SS.	Here	we	are	presenting	a	female	patient	of	age	41	yrs	was	admitted	in	out	hospital	with	chief	complaints	of	bilateral	thigh	pain	which	restrict	her	walking	with	weakness.	x-ray	of	long	bone	show	that	extensive	demineralization	of	the	bone.	Laboratory	investigations	revealed	hypokalemia	(3.2	mmol/L),	hypophosphatemia	(0.4	mmol/L),	hypocalcemia	(2.14	mmol/L)	and	hyperchloremic	metabolic	acidosis	(chlorine:	214	mmol/L;	alkaline	reserve:	14	mmol/L).	The	serum	 alkaline	 phosphatase	 levels	 were	 elevated.	 The	 serum	 levels	 of	 25-hydroxyvitamin	 D	 and	 1,25-dihydroxy	vitamin	D	were	low	and	borderline	low,	respectively,	and	the	parathyroid	hormone	level	was	90	pg/L.	Urinalysis	showed	inappropriate	alkaline	urine	(urinary	PH:	7),	glycosuria.	These	values	indicated	the	presence	 of	 both	 distal	 and	 proximal	 RTA.	 Our	 patient	 reported	 dryness	 of	 the	 mouth	 and	 eyes	 and	Schirmer’s	test	showed	xerophthalmia.	
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INTRODUCTION		Sjogren’s	syndrome	(SS)	is	a	chronic	disorder	of	the	exocrine	glands	with	associated	lymphocytic		
infiltrates	of	the	affected	glands.[1]	The	most	common	renal	disease	in	SS	is	tubulointerstitial	nephritis,	re-sponsible	for	renal	tubular	acidosis	(RTA)	in	20%	of	the	patients.[2]	Type-I	distal	RTA	(RTA	type-I)	is	char-acterized	by	non-anion	gap	hyperchloremic	acidosis	and	hypokalemia.	Type-II	proximal	RTA	(RTA	type-II)	may	occur	secondary	to	generalized	dysfunction	of	the	proximal	tubules	and	is	associated	with	increased	urinary	 excretion	 of	 glucose,	 uric	 acid,	 phosphate,	amino	 acids	 and	 protein.[3]	 Osteomalacia	 rarely	 oc-curs	as	the	first	manifestation	of	renal	tubule	disor-der	due	to	SS.	Herein,	we	report	a	patient	with	RTA-induced	osteomalacia	caused	primarily	by	SS.	[4]		
CASE	REPORT		A	female	patient	of	age	41	yrs	with	chief	complaints	of	 bilateral	 thigh	 pain	 which	 restrict	 her	 walking,	weakness	and	She	had	no	extra-articular	complaint.	The	neurological	 exam	 found	a	motor	deficit	 of	 the	pelvic	belt.	There	was	no	joint	pain	or	evidence	of	ar-thritis.	Musculoskeletal	radiography	X-ray	of	the	long	bones	 showed	 bone	 demineralization.	 An	 isotope	bone	 scan	 showed	 increased	 uptake	 at	 the	 seventh	and	eight	right	ribs,	on	the	 left	 femoral	neck	and	 in	the	pubic	rami.	She	had	a	waddling	gait	and	reported	
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pain	upon	palpation	of	the	bones.	The	MRI	showed	a	fissure	on	the	left	femoral	neck.	Urinary	strip	exami-nation	showed	glycosuria	without	proteinuria	or	he-maturia	 and	 inappropriate	 alkaline	 urine	 (urinary	pH:	7,	serum	pH:	7.37).	
 
Figure 1: X- ray of long bone showing demineraliza-
tion	The	kidney	biopsy	showed	diffuse	and	severe	tubu-lointerstitial	nephritis	with	dense	lymphoplasmocyte	infiltrates.	Thus,	our	patient	had	both	distal	and	prox-imal	renal	tubular	disorder	and	osteomalacia,	which	may	be	attributed	to	diffuse	tubulointerstitial	nephri-tis	related	to	primary	SS.	The	patient	received	alkaliz-ing	agent	(NODOSIS),	vitamin	D	(Shelcal-d),	calcium	supplements	and	steroids	at	1	mg/kg/day,	tapered	to	10	mg	daily.	Her	muscle	weakness	improved	rapidly	and	the	inability	to	walk	disappeared	gradually.	
DISCUSSION		Renal	involvement	is	not	rare	in	patients	with	SS,	alt-hough	rates	of	involvement	vary	widely	across	stud-ies.	 Chronic	 tubulointerstitial	 nephritis	 is	 the	 usual	pattern	 of	 kidney	 disease[5]	 In	 this	 case,	 the	 patho-physiological	 mechanisms	 remain	 unclear	 and	 cell	apoptosis	may	play	 a	part[6].	 Studies	have	also	 sug-gested	a	key	role	for	the	Fas/Fas	ligand	system	in	the	gland	destruction	that	characterizes	SS	[7].	Overt	or	la-tent	RTA,	caused	by	the	autoimmune	tubulointersti-tial	nephropathy,	is	a	common	extra	glandular	mani-festation	 occurring	 in	 ss	 patients.	 The	 underlying	mechanism	 is	 related	 to	deficient	H+-ATPase	pump	function.	RTA	is	characterized	by	the	presence	of	hy-perchloremic	metabolic	 acidosis	with	normal	 anion	gap.[8]	The	serum	potassium	may	be	nor	mal,	low	or	
high,	depending	on	the	type	of	RTA.	Urinary	excretion	of	phosphate	with	low	levels	of	serum	phosphate	[9],	urinary	 excretion	 of	 protein	 and	 glucosuria	 associ-ated	with	normal	glucose	are	suggestive	of	proximal	tubular	involvement	characterized	by	an	alteration	of	bone	mineralization,	frequently	related	to	alterations	in	vitamin	D	or	phosphate	metabolism.	Low	levels	of	serum	calcium,	low	serum	phosphate	except	in	cases	of	renal	osteodystrophy,	low	urinary	calcium,	low	vit-amin	 D	 concentration	 in	 blood	 and	 high	 alkaline	phosphatase.	In	proximal	RTA,	renal	phosphate	loss	is	 the	principal	 contributing	 factor	 to	 osteomalacia,	while	in	distal	RTA,	a	combination	of	acidosis	and	hy-pophosphatemia	are	implicated,	and	coexisting	vita-min	D	deficiency	may	be	an	aggravating	 factor.	The	mechanisms	 leading	 to	 osteomalacia	 may	 include	bone	buffer	release	in	response	to	metabolic	acidosis	and	acidosis-induced	dampening	of	osteoblast	alka-line	 phosphatase	 activity.	 Furthermore,	 the	 patho-genesis	of	osteomalacia	 induced	by	RTA	in	SS	 is	re-lated	to	an	autoimmune	tubulointerstitial	nephropa-thy.	The	diagnosis	of	SS	was	made	by	the	subjective	ocular	 and	 oral	 symptoms	 positive	 Schirmer’s	 test.	Glucocorticoid	treatment	has	been	used	successfully	in	patients	with	osteomalacia	related	to	RTA[10].	cor-recting	the	acidosis	by	giving	alkalinizing	agents	with	supplemental	vitamin	D	may	be	sufficient.	Our	case	report	 is	a	valuable	reminder	that	osteomalacia	can	reveal	SS	and	 that	high-dose	corticosteroid	 therapy	may	improve	renal	involvement	by	SS	as	well	as	oste-omalacia	related.	
CONCLUSION	Latent	renal	tubular	disease	is	common	is	SS,	but	is	rarely	complicated	by	osteomalacia.	Primary	SS	could	be	a	differential	diagnosis	in	women	with	acute	weak-ness,	mild	hypokalemia	and	osteomalacia.	In	spite	of	the	rarity	of	osteomalacia	revealing	SS,	this	complica-tion	should	be	taken	into	consideration	in	the	diagno-sis	of	SS	with	RTA.		
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Table 1: Laboratory investigation 
Investigation Observed value Normal value 
Sodium 140mEq/L 135-145mEq/L 
Potassium 3.2mEq/L 3.6-5.0 mEq/L 
Phosphate 0.4mmol/L 0.8-1.4 mmol/L 
Chlorine 214mEq/L 98-109mEq/L 
Serum alkaline phosphatase 370IU/L 30-120IU/L 
Serum 25 hydroxy vitamin D < 9µg/L 30-80 µg/L 
Parathyroid level 90pg/mL 7-65pg/mL 
T4 0.83ng/dL 0.7-1.5ng/dL 
TSH 1.88µIU/mL 0.1-4.5 µIU/mL 
Urine protein 0.42g/day 0.6-1.5g/day 
Urine phosphate 93mg/day 400-1300mg/day 
Urine calcium 84mg/day 93-248mg/day 
 
 T. Saranya et al., (2019) Int. J. Res. Pharmaco. Vigi & Pharmaco. Therap., 1(1), 04-06 
76   © Rubatosis Publications | International Journal of Research In Pharmacovigilance and Pharmacotherapeutics 
 
2. Jallouli	 M,	 Frigui	 M,	 Marzouk	 S,	 et	 al.	 Osteo-	malacia	 revealing	 Sjögren’s	 syndrome:	 A	 case	report.	Rev	Med	Intern	2008;29:311-4.	3. Quigley	 R.	 Proximal	 renal	 tubular	 acidosis.	 J	Nephrol	2006;19	Suppl	9:S41-5.		4. Hajjaj-Hassouni	 N,	 Guedira	 N,	 Lazrak	 N,	 et	 al.	Osteomalacia	 as	 a	 presenting	 manifestation	 of	Sjögren’s	 syndrome.	 Rev	 Rhum	 Engl	 Ed	 1995;	62:529-32.		5. Basak	RC,	Sharkawi	KM,	Rahman	MM,	Swar	MM.	Distal	 renal	 tubular	 acidosis,	 hypokalemic	paralysis,	 nephrocalcinosis,	 primary	hypothyroidism,	 growth	 retardation,	osteomalacia	 and	 osteoporosis	 leading	 to	pathological	fracture:	A	case	report.	Oman	Med	J	2011;26:271-4	6. Matsumura	 R,	 Umemiya	 K,	 Kagami	 M,	 et	 al.	Glandular	 and	 extra	 glandular	 expression	 of	 the	Fas–Fas	 ligand	 and	 apoptosis	 in	 patients	 with	Sjogren’s	 syndrome.	 Clin	 Exp	 Rheumatol	1998;16:561-8.	7. Siamopoulos	KC,	Elisaf	M,	Drosos	AA,	Mavridis	AA,	Moutsopoulos	 HM.	 Renal	 tubular	 acidosis	 in	primary	 Sjögren’s	 syndrome.	 Clin	 Rheumatol	1992;11:226-30.	8. Aerts	 J,	 Vigouroux	 C,	 Fournier	 P,	 Cariou	 D,	Pasquier	P.	Osteomalacia	of	renal	origin	disclosing	Gougerot-Sjogren	 syndrome.	 Rev	 Med	 Interne	1994;15:43-7.	9. Fulop	 M,	 Mackay	 M.	 Renal	 tubular	 acidosis,	Sjögren	Syndrome,	and	bone	disease.	Arch	Intern	Med	2004;164:905-9.	10. El-Mallakh	 RS,	 Bryan	 RK,	 Masi	 AT,	 Kelly	 CE,	Rakowski	KJ.	Long	term	 low-dose	glucocorticoid	therapy	associated	with	remission	of	overt	renal	tubular	acidosis	in	Sjögren’s	syndrome.	Am	J	Med	1985;79:509-14.	
